Clinical Trials Directory

Trials / Completed

CompletedNCT02373735

Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes

Effect of Stroke Volume Variation Guided Fluid Therapy on the Blood Loss and Postoperative Outcomes in Radical Cystectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the effect of stroke volume variation (SVV) guided fluid therapy on the blood loss and postoperative outcomes in radical cystectomy.

Detailed description

The purpose of this study is to investigate the effect of stroke volume variation(SVV) guided fluid therapy on the blood loss and postoperative outcomes in radical cystectomy. Patients were randomized to fluid management to maintain \<10% SVV (group A), or to undergo fluid management during radical cystectomy to maintain SVV 10-20% (group B). Intraoperative blood loss and hemodynamic parameters, perioperative laboratory data, and postoperative complications were compared between two groups.

Conditions

Interventions

TypeNameDescription
OTHERcrystalloidGroup A (SVV \<10%): infuse crystalloid 6-10 ml/kg/hr during surgery. Group B (SVV 10-20%): infuse crystalloid 2-4 ml/kg/hr until cystectomy, 6-10 ml/kg/hr after cystectomy
OTHERcolloidGroup A (SVV \<10%): infuse colloid 200 ml if SVV is ≥ 10%. Group B (SVV 10-20%): infuse colloid 200 ml if SVV is \> 20%
OTHERmannitolGroup B (SVV 10-20%): infuse mannitol 0.5 g/kg if SVV is \< 10%
OTHERlasixGroup B (SVV 10-20%): infuse lasix 5 mg if SVV is \< 10%

Timeline

Start date
2015-03-01
Primary completion
2015-11-01
Completion
2015-12-01
First posted
2015-02-27
Last updated
2015-12-30

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02373735. Inclusion in this directory is not an endorsement.